MYASTHENIA GRAVIS
Clinical trials for MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug trial for debilitating muscle disease halted after enrolling just six patients
Disease control TerminatedThis study tested whether an oral drug called tolebrutinib could help control symptoms in adults with moderate-to-severe generalized myasthenia gravis, a disease that causes severe muscle weakness. Participants took either the drug or a placebo pill for 26 weeks while continuing …
Matched conditions: MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Trial halted early: could a common nausea drug help MG patients tolerate treatment?
Symptom relief TerminatedThis study aimed to see if adding the anti-nausea drug ondansetron could help people with myasthenia gravis better tolerate the stomach side effects (like nausea and diarrhea) of pyridostigmine, a standard medication. It was a small, short-term trial for adults who either had tro…
Matched conditions: MYASTHENIA GRAVIS
Phase: PHASE2 • Sponsor: DAS-MG, Inc • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC